In one paragraphArticle in Neurology(R) neuroimmunology & neuroinflammation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from itWhat it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
23 authors.
Gemma Olivé-CireraNeuroimmunology Program, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS)-CaixaResearch Institute (CRI), University of Barcelona, Spain.ORCID 0000-0002-0880-4260 Elianet Gisell FonsecaNeuroimmunology Program, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS)-CaixaResearch Institute (CRI), University of Barcelona, Spain.ORCID 0000-0002-3613-3185 Mar GuaspNeuroimmunology Program, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS)-CaixaResearch Institute (CRI), University of Barcelona, Spain.ORCID 0000-0002-0110-5213 Ludovica FalcioniNeuroimmunology Program, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS)-CaixaResearch Institute (CRI), University of Barcelona, Spain.ORCID 0009-0007-3194-4898 Anna FettaNeuroimmunology Program, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS)-CaixaResearch Institute (CRI), University of Barcelona, Spain.ORCID 0000-0003-0175-6486 Raquel Ruiz GarcíaNeuroimmunology Program, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS)-CaixaResearch Institute (CRI), University of Barcelona, Spain.ORCID 0000-0002-8403-3613 Elisabet PoyatosImmunology Laboratory, Sant Joan de Déu Children's Hospital, University of Barcelona, Barcelona, Spain.ORCID 0000-0002-8969-2140 Ana Beatriz SerafimNeuroimmunology Program, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS)-CaixaResearch Institute (CRI), University of Barcelona, Spain.ORCID 0000-0003-3368-3779 Gianni IppolitiDepartment of Pathology, Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT-CERCA), Universitat Autònoma de Barcelona, Sabadell, Spain.ORCID 0000-0002-4444-2391 Armando RequesDepartment of Pathology, Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT-CERCA), Universitat Autònoma de Barcelona, Sabadell, Spain.ORCID 0000-0002-7197-9354 Laura Naranjo RondánImmunology Service, Centre Diagnòstic Biomèdic (CDB)-Hospital Clínic de Barcelona, Spain.ORCID 0000-0001-9295-1468 Marianna SpatolaNeuroimmunology Program, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS)-CaixaResearch Institute (CRI), University of Barcelona, Spain.ORCID 0000-0003-2548-0429 Yolanda BlancoNeuroimmunology Program, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS)-CaixaResearch Institute (CRI), University of Barcelona, Spain.ORCID 0000-0002-1834-0498 Eugenia Martinez-HernandezNeuroimmunology Program, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS)-CaixaResearch Institute (CRI), University of Barcelona, Spain.ORCID 0000-0002-8317-7068 Francesc GrausNeuroimmunology Program, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS)-CaixaResearch Institute (CRI), University of Barcelona, Spain.ORCID 0000-0002-8924-8322 Maria SepulvedaNeuroimmunology Program, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS)-CaixaResearch Institute (CRI), University of Barcelona, Spain.ORCID 0000-0002-3078-645X Romana HöftbergerDivision of Neuropathology and Neurochemistry, Department of Neurology and Comprehensive Center for Clinical Neurosciences and Mental Health, Medical University of Vienna, Austria; and.ORCID 0000-0002-5769-1100 Lidia SabaterNeuroimmunology Program, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS)-CaixaResearch Institute (CRI), University of Barcelona, Spain.ORCID 0000-0001-8556-6166 Albert SaizNeuroimmunology Program, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS)-CaixaResearch Institute (CRI), University of Barcelona, Spain.ORCID 0000-0002-5793-8791 Josep DalmauNeuroimmunology Program, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS)-CaixaResearch Institute (CRI), University of Barcelona, Spain.ORCID 0000-0001-5856-2813 Thais ArmangueNeuroimmunology Program, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS)-CaixaResearch Institute (CRI), University of Barcelona, Spain.ORCID 0000-0001-6192-6171 Spanish Pediatric Autoimmune Encephalitis study group
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
BACKGROUND AND
objectivesAlthough acute disseminated encephalomyelity (ADEM) can be myelin oligodendrocyte glycoprotein-IgG (MOG-IgG) positive or negative, it is unclear whether other MOG-antibody-associated disease (MOGAD)-like encephalitis syndromes occur without MOG-IgG. We aimed to define the frequency, clinico-radiologic features, outcomes, and antibody associations of such cases in children.
methodsProspective cohort study of children (<18 years) with encephalitis meeting clinico-radiologic MOGAD criteria, regardless of MOG-IgG status. Serum from all patients and CSF when available were tested by live cell-based assays (CBA-IIF, CBA-FACS) at 2 laboratories. Brain MRIs were centrally reviewed for MOGAD-like patterns (ADEM, cortical encephalitis, isolated/predominant central gray matter). Additional testing included CBAs for MOG-IgA, MOG-IgM, PLP1-IgG, glial fibrillary acidic protein-IgG, and AQP4-IgG, along with rat brain immunohistochemistry.
resultsAmong 160 patients with MOGAD-like encephalitis, 120 were MOG-IgG positive and 40 negative (20 ADEM, 11 cortical encephalitis, 9 isolated/predominant central gray matter encephalitis). Clinical-radiologic features were broadly comparable between groups, including lesion distribution, frequency of associated longitudinally extensive transverse myelitis, lesion resolution, and functional outcomes. Relapses were more frequent in MOG-IgG-positive patients (22, 18% vs 1, 3%; DISCUSSION: Children can develop the full spectrum of MOGAD-like encephalitis without MOG-IgG. Clinical features and immunotherapy response are similar to MOGAD, but relapses are uncommon.
Indexed as
EncephalitisMyelin-Oligodendrocyte GlycoproteinMyelin Oligodendrocyte Glycoprotein Antibody-Associated DiseaseAdolescentAnimalsAutoantibodiesChildChild, PreschoolFemaleHumansImmunoglobulin GInfantMaleProspective StudiesAutoantibodiesImmunoglobulin GMOG protein, humanMyelin-Oligodendrocyte Glycoprotein
Identifiers
PMID42636412
PMCPMC13504189
What OpenQuestion holds
Textmetadata
Read underepoch 390